Next Article in Journal
Oral Administration of Chaetoceros gracilis—A Marine Microalga—Alleviates Hepatic Lipid Accumulation in Rats Fed a High-Sucrose and Cholesterol-Containing Diet
Previous Article in Journal
Protein Intake Is Associated with Blood Pressure and Cholesterol Levels in Italian Older Adults: A Cross-Sectional Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Neogrisphenol A, a Potential Ovarian Cancer Inhibitor from a New Record Fungus Neohelicosporium griseum

1
School of Food and Pharmaceutical Engineering, Guizhou Institute of Technology, Guiyang 550003, China
2
Center of Excellence in Fungal Research, Mae Fah Luang University, Chiang Rai 57100, Thailand
3
School of Science, Mae Fah Luang University, Chiang Rai 57100, Thailand
4
Engineering and Research Center for Southwest Bio-Pharmaceutical Resources of National Education Ministry of China, Guizhou University, Guiyang 550025, China
5
College of Life Sciences, Guizhou University, Guiyang 550025, China
6
Department of Health Management, Guiyang Healthcare Vocational University, Guiyang 550081, China
*
Authors to whom correspondence should be addressed.
These authors equally contributed to this work.
Metabolites 2023, 13(3), 435; https://doi.org/10.3390/metabo13030435
Submission received: 18 February 2023 / Revised: 3 March 2023 / Accepted: 13 March 2023 / Published: 16 March 2023
(This article belongs to the Section Microbiology and Ecological Metabolomics)

Abstract

:
From the rice fermentation product of a new record fungus, Neohelicosporium griseum, two new polyketides, neogrisphenol A (1) and neogrisphenol B (2), one new isochroman-1-one, (S)-6-hydroxy-7-methoxy-3,5-dimethylisochroman-1-one (3), and four known compounds (47) were isolated. Their structures were determined using 1D- and 2D-NMR, mass spectrometry, and chemical calculations. The C-3~C-2′ polymerization mode between the two α-naphthalenone derivative moieties is uncommon in compounds 1 and 2. Meanwhile, compounds 12 and 5 exhibited antibacterial activity against Bacillus subtilis, Clostridium perfringens, Staphylococcus aureus, and Staphylococcus aureus, with MIC values ranging between 16 and 31 µg/mL. In addition, compound 5 showed antifungal activity against Sclerotinia sclerotiorum and Phytophthora nicotianae var. nicotianae, with respective IC50 values of 88.14 ± 2.21 µg/mL and 52.36 ± 1.38 µg/mL. Compound 1 showed significant cytotoxicity against A2780, PC-3, and MBA-MD-231 cell lines with respective IC50 values of 3.20, 10.68, and 16.30 µM, and the cytotoxicity against A2780 cells was even higher than that of cisplatin (CDDP). With an IC50 value of 10.13 µM, compound 2 also exhibited cytotoxicity against A2780. The in vitro results showed that compound 1 inhibited A2780 cell proliferation, induced apoptosis, and arrested the cell cycle at the S-phase in a concentration-dependent manner.

1. Introduction

Secondary metabolites of fungi have enormous potential, particularly for drug discovery [1]. More than half of the compounds isolated from fungi were antibacterial, antifungal, or antitumor [1]. Research on secondary metabolites of fungi concentrated primarily on endophytic fungi of medicinal plants, whereas research on secondary metabolites of saprophytic fungi was relatively uncommon [2].
Helicosporous hyphomycetes, such as the species of Helicosporium, Helicoma, Helicomyces, and Tubeufia, are capable of producing a variety of bioactive compounds [3,4,5,6,7,8,9]. The vast majority of helicosporous hyphomycetes are members of the family Tubeufiaceae (Tubeufiales, Dothideomycetes) [10]. However, this family study focuses primarily on morphology and phylogeny [10,11], and reports on secondary metabolites are scarce.
In this study, bioassay-guided isolation led to the discovery of three new compounds [two new polyketide derivatives, neogrisphenol A (1) and neogrisphenol B (2), and a new isochroman-1-one derivative named (S)-6-hydroxy-7-methoxy-3,5-dimethylisochroman-1-one (3)] and four known compounds from the EtOAc extracts of the rice fermentation product of a new record fungus, Neohelicosporium griseum. Compounds 1 and 2 have a rare C-3~C-2′ linkage between the cyclohexanone ring of one α-naphthalone derivative and the cyclohexanone ring of another α-naphthalone derivative, which has not been reported in natural or synthetic products. The antimicrobial and cytotoxic activities of compounds 17 were evaluated. Compound 1 exhibited significant cytotoxicity against the A2780 cell line with IC50 values of 3.20 µM, higher than that of cisplatin (CDDP). The results showed that this compound might serve as a potential inhibitor of ovarian cancer.

2. Materials and Methods

2.1. General Experimental Procedure

Ultraviolet-visible (UV/Vis) spectra were acquired using a UV-Vis spectrophotometer, the UV-5300 (Hitachi, Tokyo, Japan). Infrared (IR) spectra were measured on a Bruke Vertex 80 (KBr disks) infrared spectrometer. Optical rotations were recorded in methanol (MeOH) solution on an AUTOPOL1 polarimeter at 28 °C (Rudolph, Wilmington, MA, USA). CD spectra were obtained on a J-810 circular dichroism spectropolarimeter (JASCO Corp., J-810, Tokyo, Japan). Electro-spray ionization mass spectrometry (ESIMS) and high-resolution electrospray ionization mass spectrometry (HRESIMS) analyses were measured on a Waters Xevo TQS and a Waters Xevo G2S Q-TOF LC/MS, respectively. NMR spectra were recorded on a Bruker 600 MHz instrument, and tetramethylsilane (TMS) was used as an internal standard. Column chromatography was performed on silica gel (200−300 mesh, Qingdao Marine Chemical Co., Ltd., Qingdao, China) and Sephadex LH-20 (Amersham Biosciences, Uppsala, Sweden), respectively. HPLC analysis was performed on an Agilent 1260 with a C18 column (Agilent Extend-C18, 4.6 × 250 mm, 5 μm, 1 mL/min). HPLC separation was performed on Shimadzu Soviet production LC-16P with an ODS column (Silgreen C18AB, 10 × 250 mm, 5 μm, 180 Å, 3 mL/min). Cell apoptosis and cycle kits were purchased from BD Biosciences (San Jose, CA, USA).

2.2. Fungal Taxonomy and Identification

Decaying wood samples were collected randomly from sites in Guiyang Forest Park, China. The specimen examination, micromorphological study, DNA extraction, PCR amplification, sequencing, and phylogenetic analysis were conducted using the method described in Lu et al. [12].

2.3. Fermentation, Extraction, and Isolation

The strain of Neohelicosporium griseum was cultured on PDA at 28 °C for 10 days and then was inoculated into 20 × 250 mL Erlenmeyer flasks, each containing a 125 mL liquid medium (maltose 20 g, sodium glutamate 10 g, potassium dihydrogen phosphate 0.5 g, magnesium sulfate 0.3 g, glucose 10 g, yeast powder 3 g, mannitol 20 g, tap water 1 L). These flasks were incubated on a shaking table at 28 °C and 180 RPM for 7 days. About 5 mL of the seed liquid was transferred to a 200-mL plastic bag prepared from 50 g rice and 55 mL of distilled water. These bags were incubated at 28 °C under static conditions for 3 months. A total of 400 bags were fermented.
The fermented product was extracted three times with ethyl acetate (EtOAc)/methanol (10:1) (each 50 L), and the combined EtOAc/methanol (10:1) solutions were dried in vacuo to yield 99.4 g of crude extract. The 99.4 g of crude extract was subjected to column chromatography (CC) over silica gel (PE/EtOAc, v/v, 100:0→0:100) to give 20 fractions (Fr.1–20). Of these, Fr.12 was separated with Sephadex LH-20 in MeOH to yield 4 subfractions (Fr.12.1–12.4). Sephadex LH-20 was used to separate Fr.12.4 into two subfractions (Fr.12.4.1–12.4.2) in MeOH. Fr.12.4.2 was further purified by RP-HPLC with MeOH/H2O (50:50, 3 mL/min) to afford 4 (tR = 18.5 min, 3.0 mg). Fr.12.3 was chromatographed again with silica gel (PE/EtOAc, v/v, 7:3) to afford 4 subfractions (Fr.12.3.1–12.3.4). Fr.12.3.2 was further purified by RP-HPLC with MeOH (3 mL/min) to afford 7 (tR = 13.0 min, 6.3 mg). Fr.15 was divided into 4 subfractions (Fr.15.1–15.4) using Sephadex LH-20 in MeOH. Fr15.3 was further purified by RP-HPLC with MeOH/H2O (60:40, 3 mL/min) to afford 1 (tR = 10.3 min, 140.0 mg) and 5 (tR = 13.4 min, 12.4 mg). Seven subfractions (Fr.18.1–18.7) of Fr.18 were obtained after separation using Sephadex LH-20 in MeOH. Fr18.2 was further purified by RP-HPLC with MeOH/H2O (35:65, 3 mL/min) to afford 3 (tR = 16.6 min, 16.5 mg). Fr.18.4 was further separated with Sephadex LH-20 in CHCl2/MeOH (1:1) to yield 3 subfractions (Fr.18.4.1–18.4.3). Fr.18.4.3 was further purified by RP-HPLC with MeOH/H2O (40:60, 3 mL/min) to afford 6 (tR = 18.2 min, 91.0 mg). Fr18.7 was further purified by RP-HPLC with MeOH/H2O (40:60, 3 mL/min) to afford 2 (tR = 22.0 min, 6.0 mg).

2.4. Biological Assays

Antimicrobial and Cytotoxic Activities of Compounds 17

Compounds were evaluated for their antimicrobial activity against two fungi (Candida albicans and C. glabrata), three agricultural pathogenic fungi (Fusarium graminearum, Phytophthora nicotianae var. nicotianae, Sclerotinia sclerotiorum), five Gram-positive bacteria (Bacillus subtilis, Clostridium perfringens, Ralstonia solanacearum, Staphylococcus aureus, MRSA strain Staphylococcus aureus), and three Gram-negative bacteria (Escherichia coli, Paratyphoid fever, Pseudomonas aeruginosa), using ciprofloxacin as a positive control against Gram-positive and Gram-negative bacteria, while ketoconazole was used as an antifungal positive control. In addition, the compounds’ cytotoxicities against three mammalian cell lines (human ovarian cancer A2780, human prostate cancer PC-3, and human breast cancer MBA-MD-231 cell lines) were examined by the MTT method, using cisplatin (CDDP) as the positive control against A2780 and PC-3, while adriamycin was used as a positive control against MBA-MD-231. The A2780 cell line was purchased from Xiamen Immocell Biotechnology Co., Ltd. (Xiamen, China). The PC-3 cell line was purchased from Shanghai Zhongqiao Xinzhou Biological Technology Co., Ltd. (Shanghai, China). The MBA-MD-231 cell line was purchased from Cell bank of Chinese Academy of Sciences (Shanghai, China). Following our standard protocols, all bioactivity assays were carried out [13,14].

2.5. Effect of Neogrisphenol A on the Growth of A2780 Cells

2.5.1. Cell Culture and Compound Treatment

The A2780 cells were maintained in Roswell Park Memorial Institute (RPMI) 1640 medium with 10% fetal bovine serum (FBS) and 1% Penicillin-Streptomycin Solution (100 mg/L streptomycin and 1 × 105 U/L penicillin) in a 37 °C incubator chamber with 5% CO2. A stock solution of 2 × 104 µmol/L was prepared by dissolving neogrisphenol A (abbreviated as NeoA) in DMSO.

2.5.2. Cell Proliferation Assay

A2780 cells were plated in a 96-well plate with 5 × 103 cells/well, and various NeoA (1.25, 2.5, 5, 10, and 20 µmol/L) concentrations were added and incubated for 24, 48, and 72 h. Each concentration consisted of five multiple pores. The number of cells and morphological changes in the cells were observed under an inverted fluorescence microscope. An amount of 20 µL of MTT (5 mg/mL) reagent was added, and the plates were incubated for 4 h in the incubator chamber. The supernatant was discarded by centrifugation, and 150 µL of DMSO was added. The absorbance was measured at 490 nm, and the inhibition rate of cell proliferation was calculated: the inhibition rate =1 (OD processing/OD control) × 100%.

2.5.3. Cell Apoptosis Assay

In order to detect the effect of NeoA on the apoptosis of A2780 cells, we selected to use the apoptosis detection kit. The A2780 cells were seeded into 6-well plates with 3 × 105 cells/well and incubated with NeoA (3.0, 6.0, and 12.0 µmol/L) and 0.1% DMSO for 24 h. Cells were digested and collected with trypsin without ethylenediaminetetraacetic acid (EDTA), washed twice with phosphate-buffered saline (PBS), and mixed with 500 µL of PBS to form a cell suspension. We added 5.0 µL of annexin V-FITC and 5.0 µL of PI to the cell suspension and incubated it for 30 min in the dark. Finally, the apoptosis rate of each concentration group was assessed by flow cytometry.

2.5.4. Cell Cycle Assay

RNase A and PI staining kit used the effects of NeoA in the cell cycle of A2780. The process of inoculating and treating cells is described in “Cell Apoptosis Assay”. The cells were digested and collected with trypsin-containing EDTA and fixed in 70% pre-cooled ethanol at 4 °C for more than 12 h. The cells were then washed twice with PBS, bathed in 5 µL RNase A at 37 °C for 30 min, followed by 25 µL PI solution at room temperature, and stained in the dark for 15 min. The changes in the cell cycle were analyzed by flow cytometry.

3. Results

3.1. Fungal Taxonomy

Neohelicosporium griseum (Berk. and M.A. Curtis) Y.Z. Lu and K.D. Hyde, Fungal Diversity 92: 241 (2018) (Figure 1).
Index Fungorum: IF 554877; Facesoffungi number: FoF 04805.
Saprobic on decaying wood in the terrestrial habitat in a mountain. Sexual morph: undetermined. Asexual morph: Colonies on the natural substratum are superficial, gregarious, and covered with masses of crowded, glistening white conidia. Conidiophores macronematous, mononematous, erect, flexuous, cylindrical, 26–150 × 4–8 μm, ( x ¯ = 88 × 6 μm, n = 20), sparsely branched, septate, arising directly on the substrate, pale brown, smooth-walled. Conidiogenous cells are holoblastic, mono- to polyblastic, integrated, terminal or intercalary, cylindrical, 9–14 × 5–6 μm wide ( x ¯ = 12 × 5.5 μm, n = 20), with denticles that are pale brown and smooth-walled. Conidia solitary, acropleurogenous, helicoid, tightly coiled 11/2 − 31/5 times, becoming loosely coiled in water, rounded at the tip, 27–32 × 2–4.5 μm wide ( x ¯ = 28.5 μm × 3.5 μm, n = 20), 119–200 μm long, multi-septate, and hyaline.
Material examined: China, Guizhou Province, Guiyang City, Guiyang Forest Park, on decaying wood in a terrestrial habitat in the mountain, 14 September 2020, Jian Ma and Yongzhong Lu, GYSLGY1 (GZAAS 22-2002); living culture, GZCC 22-2002. GenBank accession numbers: OP470642 (ITS), OP470641 (LSU), OP698069 (RPB2), OP698068 (TEF1α).
Notes: Using morphological and phylogenetic evidence, Lu et al. [12] synonymized Helicosporium griseum, H. lumbricoides, and H. bellus as Neohelicosporium griseum. Based on the results of a multilocus phylogenetic analysis, a new isolate collected from a terrestrial habitat was determined to be Neohelicosporium griseum in this study (Figure 2). Moreover, Neohelicosporium griseum is a new record for China. We observed that the new isolate is phylogenetically distinct from the other four strains. Consequently, we examined pairwise dissimilarities of DNA sequences and discovered there are a few noticeable nucleotide differences between the new isolate and the other four known isolates in ITS and LSU sequence data (Table 1), which provides strong evidence that they belong to the same species. What must be emphasized is that the morphological characteristics of the new isolate differ from those of previously described specimens due to its larger conidia (27–32 μm diam., 2–4.5 μm wide vs. 12–15 μm diam., 1–2.5 μm wide) [15] than Helicosporium griseum. According to the suggestions for helicosporous hyphomycetes species identification by Lu et al. [12], the size of conidia is an essential factor in identifying helicosporous fungi. However, we cannot compare the morphology of the new isolate with the morphology of the other strains that provided molecular data due to the absence of morphological characteristics in the previously described strains. In addition, specimens with morphological characteristics are missing molecular information. It suggests that there are likely numerous incorrect taxonomic identifications within this group. Therefore, additional taxonomic research on helicosporous fungi is required.

3.2. Spectroscopic Data

Neogrisphenol A (1): earthy yellow powder; [α ] D 28 +510 (c 4.0, MeOH); UV (MeOH) λmax (log ε) 221 (4.42), 280 (3.13), 339 (3.66) nm; ECD (c 5.7 × 10−4 M, MeOH) λmax (∆ε) 200 (+1.53), 211 (−2.09), 230 (+6.80), 254 (−2.16), 276 (−0.77), 314 (−3.79), 367 (+9.47) nm; IR (KBr) Vmax 3429, 3051, 2923, 2855, 1635, 1454, 1338, 1241, 1210, 1128 cm−1 (Figure S9); 1H and 13C NMR, Table 2; HRESIMS at m/z 375.08386 [M + Na]+ (calcd. for C20H16O6Na, 375.083909).
Neogrisphenol B (2): brownish black solid; [α ] D 28 +160 (c 0.5, MeOH); UV (MeOH) λmax (log ε) 223 (3.33), 286 (2.59), 336 (2.92) nm; ECD (c 5.4 × 10−4 M, MeOH) λmax (∆ε) 200 (+10.07), 238 (−6.31), 262 (+2.39), 309 (−11.16), 358 (+20.04) nm; IR (KBr) Vmax 3403, 2924, 2855, 1614, 1458, 1383, 1245, 1169 cm−1 (Figure S18); 1H and 13C NMR, Table 2; HRESIMS at m/z 391.07761 [M + Na]+ (calcd. for C20H16O7Na, 391. 078824).
(S)-6-hydroxy-7-methoxy-3,5-dimethylisochroman-1-one (3): rufous solid; [α]28 D +52 (c 0.4, MeOH); UV (MeOH) λmax (logε) 213 (3.11), 243 (2.45), 266 (2.84), 285 (2.41), 305 (2.63) nm; ECD (c 9.0 × 10−4 M, MeOH) λmax (∆ε) 200 (+2.10), 215 (−1.23), 236 (+5.25), 254 (+0.53), 270 (+2.71), 286 (+0.80), 303 (+1.58) nm; IR (KBr) Vmax 3418, 2932, 1690, 1596, 1260, 1122, 1084 cm−1 (Figure S26); 1H and 13C NMR, Table 3; HRESIMS at m/z 245.07921 [M + Na]+ (calcd. for C12H14O4Na, 245.078430).

3.3. Structure Elucidation of Compounds 17

Compound 1 (Figure 3) was obtained as an earthy yellow powder, and its molecular formula was established as C20H16O6 based on HRESIMS data at 375.08386 [M + Na]+ (calcd. For C20H16O6Na, 375.083909), indicating 13 degrees of unsaturation. The 1D NMR data (Table 2 and Figures S1, S2 and S4) of 1 and HSQC correlations showed signals for two 1,2,3-trisubstituted benzene rings, two carbonyls, a methylene, a methine, and two olefinic protons [6.74 (d, J = 10.0 Hz, 1H), 6.35 (d, J = 10.0 Hz, 1H)], as well as four exchangeable protons [12.19 (s, 1H), 12.17 (s, 1H), 6.10 (s, 1H), 5.52 (d, J = 4.2 Hz, 1H)]. The COSY correlations of H-3 with H-2a and H-4 along with the HMBC correlations of H-2a/C-1, C-3, C-4, H-2b/C-1, C-3, C-4, H-3/C-1, and H-4/C-2, C-3, C-4a, C-5, and C-8a indicated the presence of a substituted tetralone moiety (Figure 4 and Figures S3, S5 and S6). The observed HMBC correlations from 2′-OH- to C-2′, C-3′, from H-3′ to C-1′, C-4a’, and from H-4′ to C-2′, C-4a’, C-5′, and C-8a’ implied the presence of another substituted α-(2H)-naphthalenone moiety (Figure 4). The observed HMBC correlations from 2′-OH to C-3, from H3′ to C-3, from H-2a to C-2′, and from H-3 to C-1′ and C-3′ suggested that there is a C-3~C-2′ linkage between the two α-naphthalenone moieties. The observed HMBC correlations from 8-OH to C-7, C-8, and C-8a and from 8′-OH to C-7′, C-8′, and C-8a’ indicated that 8-OH attached to C-8 and 8′-OH attached to C-8′, respectively. Thus, the planar structure of compound 1 was determined (Figure 1). The relative configuration of compound 1 was confirmed by analysis of the coupling constants, NOESY correlations (Figure 4), and 13C-NMR calculations (Figure 5). The large coupling constant of Hax-2a with Hax-3 (J = 13.3 Hz) indicated a Jaa coupling between Hax-2a and Hax-3, and a Jae coupling between Hax-3 and Heq-2b (J = 3.9 Hz). The very small coupling constant of Hax-3 with H-4 (J = 2.0 Hz) indicated a Jae coupling between them. Thus, H-3 and 4-OH were in the opposite orientations of the substituted tetralone moiety plane. The NOESY correlation of H-2a with 4-OH further confirmed this deduction. However, since the C-3~C-2′ bond can rotate, the relative configuration of the right part of compound 1 cannot be determined. Thus, we performed theoretical NMR chemical shift calculations for the two diastereomers 1a and 1b of 1 using the gauge-independent atomic orbital (GIAO) 13C NMR calculations [16]. The calculated 13C NMR chemical shifts of 1b showed the best agreement with the experimental values (Figure 5). Furthermore, DP4+ analysis predicted that 1b was the most likely candidate with 100% probability (Table S2). ECD calculations were used to determine the absolute configuration of 1, and they revealed that the experimental and calculated ECDs for (3R,4R,2′S)-1 are in agreement (Figure 6). Thus, compound 1 was identified as (3R,4R,2′S)-1 and named neogrisphenol A.
Compound 2 (Figure 3) was obtained as a brownish-black solid, and its molecular formula was established as C20H16O7 based on HRESIMS data at 391.07761 [M + Na]+ (calcd. For C20H16O7Na, 391. 078824), indicating 13 degrees of unsaturation. The molecular formula of compound 2 has only one more oxygen atom than compound 1, and the 1H-NMR spectrum is very similar, except for one less aromatic proton and one more exchangeable proton, suggesting that compound 2 has only one more phenolic hydroxyl group (10.94, s, 1H) than compound 1. The 1D and 2D NMR data of the left part of compound 2 are almost identical to those of compound 1, indicating they share the same planar structure and relative configuration of the left part (Figures S10–S15). The 1H-NMR data of compound 2 showed the two protons [6.31, (d, J = 2.2 Hz, 1H), 6.17, (d, J = 2.2 Hz, 1H)] were meta-coupling on the right benzene ring. The HSQC correlations of H-5′/C-5′, H-7′/C-7′, along with the HMBC correlations of H-5′/C-4′, C-7′, C-8a’, H-7′/ C-5, C-6, C-8, 6′-OH/C-5′, C-7′, 8′-OH/ C-7′, C-8′, C-8a’, and H-4/C-2, C-3, C-4a, C-5, and C-8a, indicated that 6′-OH was connected to C-6′ and 8′-OH connected to C-8′, respectively. The position of the carbon-carbon double bond (C3′~4′) in the right cyclohexanone ring is also the same as in compound 1, based on similar HMBC correlations (Figure S14). In addition, the HMBC correlations (Figure S14), similar to compound 1, proved the connection position is also a C-3~C-2′ linkage between the two naphthalenone derivative moieties. Thus, the planar structure of compound 2 was determined (Figure 3). In the same way, the relative configuration of compound 2 is defined as 2b (Figure 7 and Figure S41, and Tables S3 and S4). The relative configurations of compound 1 and compound 2 were assigned the same by 13C NMR calculation (Figure 7), and their experimental ECD curves were similar (Figure 6). The sign of the specific rotation is also positive, so the absolute configuration of compound 2 was defined as (3R,4R,2′S)-2 and named neogrisphenol B.
Compound 3 (Figure 1) was obtained as a rufous solid, and its molecular formula was established as C20H16O7 based on the HRESIMS data at 245.07921 [M + Na]+ (calcd. for C12H14O4Na, 245.078430), indicating 6 degrees of unsaturation. The 1D-NMR data and HSQC correlation showed signals for an aromatic proton, an exchangeable proton, a methoxyl, two methyls, one methylene, and an oxygenated methine. These data were close to those of the isochroman-1-one skeleton [17], with the exception that an aromatic proton signal was absent and one sp3-methoxyl signal (δH/C 1.98/10.6) and one oxygen-bearing sp3-methoxyl signal (δH/C 3.71/55.4) were present. The structure of the right part was confirmed by the COSY and HMBC correlations (Figure 4, Figures S21 and S23). The connection positions of the phenolic hydroxyl, methoxyl, and methyl groups on the benzene ring were determined by the key HMBC correlation from H-4a to C-5, H-8 to C-4a, C-6, C-8a, H-11 to C-7, and H-10 to C-6 (Figure 4 and Figure S23). Thus, the planar structure of compound 3 was determined. The relative configuration of compound 3 was confirmed by coupling constants. The large coupling constant of Hax-4a with Hax-3 (J = 12.4 Hz) indicated a Jaa coupling between Hax-4a and Hax-3, and a Jae coupling between Hax-3 and Heq-4b (J = 2.8 Hz). ECD calculations were used to determine compound 3′s absolute configuration, and the results showed that the experimental and computed ECDs for (3S)-3 are consistent (Figure 8). Thus, compound 3 was identified as (S)-6-hydroxy-7-methoxy-3,5-dimethylisochroman-1-one.
Compound 4 (Figure 1), C9H10O4, was a white solid, ESIMS at m/z 181.2 [M-H]- (calcd. for C9H10O4, 182.1), 363.1 [2M − H], 183.1 [M+H]+, 205.1 [M + Na]+ (calcd. for C9H10O4Na, 205.1); 1H NMR (600 MHz, DMSO-d6) δ 10.69 (s, 1H), 6.16 (t, J = 2.1 Hz, 2H), 3.79 (s, 3H), 2.27 (s, 3H); 13C NMR (150 MHz, DMSO) δ 170.2, 161.4, 161.0, 140.7, 110.2, 107.6, 100.5, 51.8, 22.1. Compound 4 was identified as methyl orsellinate [18].
Compound 5 (Figure 1), C14H14O3, was a brown oil; 1H NMR (600 MHz, DMSO-d6) δ 9.44 (s, 2H), 6.34 (ddd, J = 2.2, 1.5, 0.8 Hz, 2H), 6.24 (ddd, J = 2.2, 1.4, 0.7 Hz, 2H), 6.15 (td, J = 2.2, 2.2, 0.6 Hz 2H), 2.18 (s, 6H); 13C NMR (150 MHz, DMSO) δ 158.5, 157.6, 140.1, 111.2, 110.1, 103.0, 21.1; ESIMS at m/z 229.1 [M − H], 459.1 [2M − H] (calcd. for C14H14O3, 230.1). Compound 5 was identified as diorcinol [19,20].
Compound 6 (Figure 1), C11H10O4, was a white needle crystal; 1H NMR (600 MHz, DMSO-d6) δ 10.67 (s, 1H), 6.42 (d, J = 2.2 Hz, 1H), 6.32 (d, J = 2.2 Hz, 1H), 6.26 (d, J = 1.1 Hz, 1H), 3.80 (s, 3H), 2.12 (d, J = 1.0 Hz, 3H); 13C NMR (150 MHz, DMSO) δ 164.2, 163.2, 157.9, 154.7, 141.8, 103.1, 102.4, 100.3, 98.6, 55.8, 18.9; ESIMS at m/z 205.1 [M-H] (calcd. for C11H10O4, 206.1), 229.1 [M + Na]+ (calcd. for C11H10O4Na, 229.1), 435.0 [2M + Na]+ (calcd. for C22H20O8Na, 435.0). Compound 6 was identified as 6-hydroxy-8-methoxy-3-methyl-isocoumarin [21].
Compound 7 (Figure 1), C28H44O, was a white needle crystal; 1H NMR (600 MHz, CDCl3-d) δ 5.57 (dd, J = 5.7, 2.6 Hz, 1H), 5.39 (dt, J = 5.6, 2.8 Hz, 1H), 5.20 (qd, J = 15.3, 7.6 Hz, 2H), 3.64 (tt, J = 11.2, 4.2 Hz, 1H), 2.48 (dd, J = 4.7, 2.4 Hz, 1H), 2.28 (ddd, J = 14.0, 11.7, 2.3 Hz, 1H), 2.05 (dddd, J = 14.4, 13.2, 7.1, 4.7 Hz, 2H), 2.00–1.94 (m, 1H), 1.93–1.86 (m, 3H), 1.85 (dd, J = 7.0, 5.8 Hz, 1H), 1.81–1.56 (m, 4H), 1.54–1.43 (m, 2H), 1.38 (qd, J = 11.0, 10.6, 5.1 Hz, 1H), 1.34–1.31 (m, 1H), 1.31–1.29 (m, 1H), 1.29–1.22 (m, 3H), 1.04 (d, J = 6.7 Hz, 3H), 0.96–0.89 (m, 6H), 0.83 (dd, J = 9.1, 6.8 Hz, 6H), 0.63 (s, 3H); 13C NMR (150 MHz, CDCl3) δ 141.5, 139.9, 135.7, 132.1, 119.7, 116.4, 70.6, 55.9, 54.7, 46.4, 43.0, 43.0, 41.0, 40.6, 39.2, 38.5, 37.2, 33.2, 32.2, 28.4, 23.2, 21.3, 21.2, 20.1, 19.8, 17.8, 16.4, 12.2. Compound 7 was identified as ergosterin [22].

3.4. Antimicrobial and Cytotoxic Activities of Compounds 17

The ethyl acetate (EtOAc) extracts from the rice fermentation product of Neohelicosporium griseum showed cytotoxicity against PC3 cell lines, with IC50 values of 0.4 mg/mL, as part of our ongoing research into the medical applications of helicosporous hyphomycetes. To investigate the bioactivities of compounds 17, their antimicrobial and cytotoxic properties were evaluated. Compounds 12 and 5 exhibited moderate antibacterial activity against Bacillus subtilis, Clostridium perfringens, Staphylococcus aureus, and Staphylococcus aureus with MIC values between 16 and 31 µg/mL (Table 4). Only compound 5 exhibited antifungal activity against Sclerotinia sclerotiorum and Phytophthora nicotianae var. nicotianae, with respective IC50 values of 88.14 ± 2.21 µg/mL and 52.36 ± 1.38 µg/mL (Table 5). Compound 1 showed significant cytotoxicity against the A2780, PC-3, and MBA-MD-231 cell lines, with respective IC50 values of 3.20, 10.68, and 16.30 µM (Table 6). Compound 2 showed significant cytotoxicity against A2780 cell lines, with an IC50 value of 10.13 µM (Table 6).

3.5. Effect of Neogrisphenol A on the Growth of A2780 Cells

3.5.1. Effect of Neogrisphenol A on the Cell Viability of A2780 Cells

The cytotoxicity of NeoA toward cancer cells was evaluated using the MTT technique. According to Figure 9B, the growth inhibition rate of the A2780 cells increased dose-dependently with rising NeoA concentrations and peaked by 80% at 10 mol/L. As Figure 9C shows, the quantitative analysis of the IC50 values at 24 h (4.78 ±1.57 mol/L), 48 h (3.46 ± 1.19 mol/L), and 72 h (4.74 ± 0.39 mol/L) demonstrates that the inhibitory effect of NeoA on the A2780 cells was not time-dependent. Hence, it was decided to treat A2780 cells with NeoA for 24 hours in order to conduct further research. After 24 h of A2780 cell culture, dose-dependent inhibition of cell proliferation and stimulation of cell division by NeoA were observed (Figure 9D). This study suggests that NeoA may inhibit the proliferation of A2780 cells and cause apoptosis.

3.5.2. Effect of Neogrisphenol A on Apoptosis of A2780 Cells

Flow cytometry analysis showed that the number of apoptotic cells increased with the increase in NeoA concentration (Figure 9E). As shown in Figure 9G, the A2780 cells apoptosis rate increased with the increase of NeoA concentration in a concentration-dependent manner; the early and late apoptosis rates of all concentration groups differed significantly from those in the control group (DMSO), except for the low concentration group. The late apoptosis rate reached 47.80 ± 1.49% at 12 µmol/L, indicating that apoptosis induction mainly occurred in late apoptosis. This suggested that NeoA could prevent A2780 cells from proliferating by triggering early and late apoptosis.

3.5.3. Effects of Different Concentrations of Neogrisphenol A on the Cycle of A2780 Cells

The percentage of cells in the G0/G1 phase dramatically dropped as NeoA concentration increased, whereas the number of cells in the S-phase sharply increased (Figure 9F). The results of the quantitative study (Figure 9I) showed that NeoA interfered with the regulation of components that control cell cycle progression and prevented the entry of the cell cycle into the S-phase. This was shown by the increase in the number of S-phase cells with rising NeoA concentrations in comparison to the control cells (DMSO). The reduction in G0/G1 phase cells indicates that NeoA probably prevented the A2780 cells from replicating their DNA. NeoA was shown to regulate the G0/G1 and S-phases of the cell cycle to inhibit the malignant proliferation of A2780 cells.

4. Discussion

Derivatives of the α-naphthalenone dimer are primarily derived from microbial metabolites. Most of them were isolated from the fungal genus Cladosporium, named cladosporols [23], and to a lesser extent from plants, named naphthoquinones [24,25], through the carbon-carbon bond polymerization of two α-naphthalenone derivatives into a dimer. Typically, they are connected through the polymerization of the benzene ring of one α-naphthalone derivative with the benzene ring of another α-naphthalone derivative or the benzene ring of one α-naphthalone derivative with the cyclohexanone ring of another α-naphthalone derivative. The biological activities of α-naphthalenone dimer derivatives include anticancer, antimicrobial, and so on [26,27,28,29,30,31,32]. Two novel α-naphthalenone dimer derivatives were isolated and identified during the study of secondary metabolites of Neohelicosporium griseum. They have a rare 3~2′ polymerization mode between the cyclohexanone ring of one α-naphthalone derivative and the cyclohexanone ring of another α-naphthalone derivative. This study demonstrated that helicosporous hyphomycetes are worthy of study, and future research may uncover additional active secondary metabolites with novel structures. Neogrisphenol A is anticipated to be a new anticancer drug with a bright future in both development and application.

5. Conclusions

Neogrisphenol A-B (12) and (R)-6-hydroxy-7-methoxy-3,5-dimethylisochroman-1-one (3) are three new polyketone derivatives isolated from the rice fermentation product of a new record fungus for China viz Neohelicosporium griseum, which is a new record for China. NOE and 13C-NMR calculations determined the relative configurations of compounds 12. The absolute configurations of compounds 12 were determined through ECD calculations. Neogrisphenol A showed extensive antibacterial activity against Bacillus subtilis, Clostridium perfringens, Staphylococcus aureus, MRSA-strain Staphylococcus aureus, and Ralstonia solanacearum. Meanwhile, neogrisphenol B exhibited antibacterial activity against the MRSA-strain Staphylococcus aureus. Diorcinol showed antifungal and antibacterial activity against Phytophthora nicotianae var. nicotianae and Sclerotinia sclerotiorum and weak antibacterial activity against Clostridium perfringens. Neogrisphenol A also showed potent inhibition on A2780, PC-3, and MBA-MD-231 cell lines, particularly A2780 cell lines, with more potency than the positive drug cis-platinum. Neogrisphenol B also exhibited cytotoxicity against A2780. Neogrisphenol A dramatically reduced the rate of proliferation of A2780 cells, induced apoptosis, and prevented the S-phase of the cell cycle in a concentration-dependent manner. It is anticipated that neogrisphenol A will be further developed and utilized as a novel anticancer chemical entity.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/metabo13030435/s1. Figure S1: 1H NMR spectrum of compound 1 (600 MHz, DMSO); Figure S2: 13C NMR spectrum of compound 1 (150 MHz, DMSO); Figure S3: 1H-1H COSY spectrum of compound 1 (DMSO); Figure S4: HSQC spectrum of compound 1 (DMSO); Figure S5: HMBC spectrum of compound 1 (DMSO); Figure S6: NOESY spectrum of compound 1 (DMSO); Figure S7: ESIMS of compound 1; Figure S8: HR-ESIMS of compound 1; Figure S9: IR (KBr) spectrum of compound 1; Figure S10: 1H NMR spectrum of compound 2 (600 MHz, DMSO); Figure S11: 13C NMR spectrum of compound 2 (150 MHz, DMSO); Figure S12: 1H-1H COSY spectrum of compound 2 (DMSO); Figure S13: HSQC spectrum of compound 2 (DMSO); Figure S14: HMBC spectrum of compound 2 (DMSO); Figure S15: NOESY spectrum of compound 2 (DMSO); Figure S16: ESIMS of compound 2; Figure S17: HR-ESIMS of compound 2; Figure S18: IR (KBr) spectrum of compound 2; Figure S19: 1H NMR spectrum of compound 3 (600 MHz, DMSO); Figure S20: 13C NMR spectrum of compound 3 (150 MHz, DMSO); Figure S21: 1H-1H COSY spectrum of compound 3 (DMSO); Figure S22: HSQC spectrum of compound 3 (DMSO); Figure S23: HMBC spectrum of compound 3 (DMSO); Figure S24: ESIMS of compound 3; Figure S25: HR-ESIMS of compound 3; Figure S26: IR (KBr) spectrum of compound 3; Figure S27: 1H NMR spectrum of compound 4 (600 MHz, DMSO); Figure S28: 3C NMR spectrum of compound 4 (150 MHz, DMSO); Figure S29: 1H-1H COSY spectrum of compound 4 (DMSO); Figure S30: HSQC spectrum of compound 4 (DMSO); Figure S31: HMBC spectrum of compound 4 (DMSO); Figure S32: ESIMS of compound 4; Figure S33: 1H NMR spectrum of compound 5 (600 MHz, DMSO); Figure S34: 13C NMR spectrum of compound 5 (150 MHz, DMSO); Figure S35: ESIMS of compound 5; Figure S36: 1H NMR spectrum of compound 6 (600 MHz, DMSO); Figure S37: 13C NMR spectrum of compound 6 (150 MHz, DMSO); Figure S38: ESIMS of compound 6; Figure S39: 1H NMR spectrum of compound 7 (600 MHz, CDCl3); Figure S40: 13C NMR spectrum of compound 7 (150 MHz, CDCl3); Figure S41: Optimized geometries of isomers of 1 and 2 at B3LYP/6-31G(d) level; Table S1: Optimized cartesian coordinates of conformers of 1 at B3LYP/6-31G(d) level; Table S2: The results of the DP4+ analysis of 1; Table S3: Optimized cartesian coordinates of conformers of 2 at B3LYP/6-31G(d) level; Table S4: The results of the DP4+ analysis of 2.

Author Contributions

The specimens in this study were collected by J.M. and Y.-Z.L.; morphological data were collected by J.M.; molecular data and phylogenetic analyses were performed by Y.-P.X. and X.-J.X.; identification, extraction, separation, and purification of metabolites by L.-J.Z., M.-Y.H., M.-L.X. and D.-G.Z.; bioassays were performed by M.-F.Y. and X.-Y.M.; L.-J.Z. wrote the original draft, and review and editing were performed by R.S.J., A.M., J.-C.K. and Y.-Z.L. All authors have read and agreed to the published version of the manuscript.

Funding

This work was funded by the Guizhou Province high-level talent innovation and entrepreneurship merit funding project (No. 202104), the China Postdoctoral Science Foundation Project (2020M683657XB), the National Natural Science Foundation of China (NSFC 31900020), the Science and Technology Foundation of Guizhou Province ([2020]1Y058), and the academic emerging project of the Guizhou Institute of Technology (GZLGXM-15).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in the article and Supplementary Materials.

Acknowledgments

Li-Juan Zhang would like to thank Mae Fah Luang University for the granting of the tuition scholarship for PhD study. Li-Juan Zhang also would like thank Shanggao Liao from Guizhou Medical University for helping to name compounds 1 and 2.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Keller, N.P. Fungal secondary metabolism: Regulation, function and drug discovery. Nat. Rev. Microbiol. 2019, 17, 167–180. [Google Scholar] [CrossRef] [PubMed]
  2. Meena, H.; Hnamte, S.; Siddhardha, B. Secondary Metabolites from Endophytic Fungi: Chemical Diversity and Application. In Advances in Endophytic Fungal Research; Springer: Cham, Switzerland, 2019; pp. 145–169. [Google Scholar] [CrossRef]
  3. Hu, H.; Guo, H.; Li, E.; Liu, X.; Zhou, Y.; Che, Y. Decaspirones F−I, Bioactive Secondary Metabolites from the Saprophytic Fungus Helicoma viridis. J. Nat. Prod. 2006, 69, 1672–1675. [Google Scholar] [CrossRef] [PubMed]
  4. Itazaki, H.; Nagashima, K.; Sugita, K.; Yoshida, H.; Kawamura, Y.; Yasuda, Y.; Matsumoto, K.; Ishii, K.; Uotani, N.; Nakai, H.; et al. Isolation and structural elucidation of new cyclotetrapeptides, trapoxins A and B, having detransformation activities as antitumor agents. J. Antibiot. 1990, 43, 1524–1532. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Nakai, H.; Nagashima, K.; Itazaki, H. Structure of a new cyclotetrapeptide trapoxin A. Acta Crystallogr. Sect. C Cryst. Struct. Commun. 1991, 47, 1496–1499. [Google Scholar] [CrossRef]
  6. Ohtsu, Y.; Sasamura, H.; Shibata, T.; Nakajima, H.; Hino, M.; Fujii, T. The novel gluconeogenesis inhibitors FR225659 and related compounds that originate from Helicomyces sp. No. 19353. II. Biological profiles. J. Antibiot. 2003, 56, 689–693. [Google Scholar] [CrossRef] [Green Version]
  7. Qian, S.Y.; Zeng, X.Y.; Qian, Y.X.; Lu, Y.Z.; He, Z.J.; Kang, J.C. A saprophytic fungus Tubeufia rubra Produces novel rubracin D and E reversing multidrug resistance in cancer cells. J. Fungi 2023, 9, 309. [Google Scholar] [CrossRef]
  8. Zeng, X.; Qian, S.; Lu, Y.; Li, Y.; Chen, L.; Qian, Y.; He, Z.; Kang, J. A Novel Nitrogen-containing Glyceride from Fungal Saprobe Tubeufia rubra Reverses MDR of Tumor Cell Lines to Doxorubicin. Rec. Nat. Prod. 2022, 16, 622–632. [Google Scholar] [CrossRef]
  9. Zheng, W.; Han, L.; He, Z.J.; Kang, J.C. A new alkaloid derivative from the saprophytic fungus Neohelicomyces hyalosporus PF11-1. Nat. Prod. Res. 2023, 1–5. [Google Scholar] [CrossRef]
  10. Lu, Y.Z.; Liu, J.K.; Hyde, K.D.; Jeewon, R.; Kang, J.C.; Fan, C.; Boonmee, S.; Bhat, D.J.; Luo, Z.L.; Lin, C.G. A taxonomic reassessment of Tubeufiales based on multi-locus phylogeny and morphology. Fungal Divers. 2018, 92, 131–344. [Google Scholar] [CrossRef]
  11. Tian, X.G.; Karunarathna, S.C.; Xu, R.; Lu, Y.; Suwannarach, N.; Mapook, A.; Bao, D.; Xu, J.; Tibpromma, S. Three New Species, Two New Records and Four New Collections of Tubeufiaceae from Thailand and China. J. Fungi 2022, 8, 206. [Google Scholar] [CrossRef]
  12. Lu, Y.-Z.; Ma, J.; Xiao, X.-J.; Zhang, L.-J.; Xiao, Y.-P.; Kang, J.-C. Four new species and three new records of helicosporous hyphomycetes from China and their multi-gene phylogenies. Front. Microbiol. 2022, 13, 1053849. [Google Scholar] [CrossRef]
  13. Wang, K.B.; Jiang, S.S.; Pu, T.; Fan, L.M.; Su, F.W.; Ye, M. Antifungal activity of phenolic monoterpenes and structure-related compounds against plant pathogenic fungi. Nat. Prod. Res. 2018, 33, 1423–1430. [Google Scholar] [CrossRef] [PubMed]
  14. Shao, L.; Marin-Felix, Y.; Surup, F.; Stchigel, A.M.; Stadler, M. Seven New Cytotoxic and Antimicrobial Xanthoquinodins from Jugulospora vestita. J. Fungi 2020, 6, 188. [Google Scholar] [CrossRef] [PubMed]
  15. Goos, R.D. On the anamorph genera Helicosporium and Drepanospora. Mycologia 1989, 81, 356–374. [Google Scholar] [CrossRef]
  16. Grimblat, N.; Zanardi, M.M.; Sarotti, A.M. Beyond DP4: An Improved Probability for the Stereochemical Assignment of Isomeric Compounds Using Quantum Chemical Calculations of NMR Shifts. J. Org. Chem. 2015, 80, 12526–12534. [Google Scholar] [CrossRef] [PubMed]
  17. Xiao, Y.W.; Liang, W.Z.; Zhang, Z.B.; Wang, Y.; Zhang, S.S.; Liu, J.T.; Chang, J.; Ji, C.J.; Zhu, D. Polyketide Derivatives from the Endophytic Fungus Phaeosphaeria sp. LF5 Isolated from Huperzia serrata and Their Acetylcholinesterase Inhibitory Activities. J. Fungi 2022, 8, 232. [Google Scholar] [CrossRef]
  18. Tram, N.T.T.; Anh, D.H.; Thuc, H.H.; Tuan, N.T. Investigation of chemical constituents and cytotoxic activity of the lichen Usnea undulata. Vietnam. J. Chem. 2020, 58, 63–66. [Google Scholar] [CrossRef] [Green Version]
  19. Tian, Y.Q.; Lin, X.P.; Liu, J.; Kaliyaperumal, K.; Ai, W.; Ju, Z.R.; Yang, B.; Wang, J.; Yang, X.W.; Liu, Y. Ascomycotin A, a new citromycetin analogue produced by Ascomycota sp. Ind19F07 isolated from deep sea sediment. Nat. Prod. Res. 2014, 29, 820–826. [Google Scholar] [CrossRef]
  20. Yurchenko, A.N.; Smetanina, O.F.; Kalinovsky, A.I.; Pivkin, M.V.; Dmitrenok, P.S.; Kuznetsova, T.A. A new meroterpenoid from the marine fungus Aspergillus versicolor (Vuill.) Tirab. Russ. Chem. Bull. 2010, 59, 852–856. [Google Scholar] [CrossRef]
  21. Wu, J.S.; Shi, X.H.; Zhang, Y.H.; Yu, J.Y.; Fu, X.M.; Li, X.; Chen, K.X.; Guo, Y.W.; Shao, C.L.; Wang, C.Y. Co-cultivation with 5-Azacytidine Induced New Metabolites from the Zoanthid-Derived Fungus Cochliobolus lunatus. Front. Chem. 2019, 7, 763. [Google Scholar] [CrossRef] [Green Version]
  22. Wang, F.; Tan, J.; Liu, J. Vibratilicin: A Novel Compound from the Basidiomycete Cortinarius vibratilis. Helvetica Chim. Acta 2010, 87, 1912–1915. [Google Scholar] [CrossRef]
  23. Sakagami, Y.; Sano, A.; Hara, O.; Mikawa, T.; Marumo, S. Cladosporol, β-1, 3-glucan biosynthesis inhibitor, isolated from fungus, Cladosporium cladosporioides. Tetrahedron Lett. 1995, 36, 1469–1472. [Google Scholar] [CrossRef]
  24. Weigenand, O.; Hussein, A.A.; Lall, N.; Meyer, J. Antibacterial activity of naphthoquinones and triterpenoids from Euclea natalensis root bark. J. Nat. Prod. 2004, 67, 1936–1938. [Google Scholar] [CrossRef] [PubMed]
  25. Lall, N.; Weiganand, O.; Hussein, A.A.; Meyer, J.J.M. Antifungal activity of naphthoquinones and triterpenes isolated from the root bark of Euclea natalensis. S. Afr. J. Bot. 2006, 72, 579–583. [Google Scholar] [CrossRef] [Green Version]
  26. Zhang, F.; Zhou, L.; Kong, F.; Ma, Q.; Xie, Q.; Li, J.; Dai, H.; Guo, L.; Zhao, Y. Altertoxins with Quorum Sensing Inhibitory Activities from The Marine-Derived Fungus Cladosporium sp. KFD33. Mar. Drugs 2020, 18, 67. [Google Scholar] [CrossRef] [Green Version]
  27. Li, H.L.; Li, X.M.; Mandi, A.; Antus, S.; Li, X.; Zhang, P.; Liu, Y.; Kurtan, T.; Wang, B.G. Characterization of Cladosporols from the Marine Algal-Derived Endophytic Fungus Cladosporium cladosporioides EN-399 and Configurational Revision of the Previously Reported Cladosporol Derivatives. J. Org. Chem. 2017, 82, 9946–9954. [Google Scholar] [CrossRef]
  28. Rapuano, R.; Ziccardi, P.; Cioffi, V.; Dallavalle, S.; Moricca, S.; Lupo, A. Cladosporols A and B, two natural peroxisome proliferator-activated receptor gamma (PPARγ) agonists, inhibit adipogenesis in 3T3-L1 preadipocytes and cause a conditioned-culture-medium-dependent arrest of HT-29 cell proliferation. Biochim. Biophys. Acta (BBA) Gen. Subj. 2021, 1865, 129973. [Google Scholar] [CrossRef]
  29. Blacutt, A.; Ginnan, N.; Dang, T.; Bodaghi, S.; Vidalakis, G.; Ruegger, P.; Peacock, B.; Viravathana, P.; Vieira, F.C.; Drozd, C.; et al. An In Vitro Pipeline for Screening and Selection of Citrus-Associated Microbiota with Potential Anti-“Candidatus Liberibacter asiaticus” Properties. Appl. Environ. Microbiol. 2020, 86, e02883-19. [Google Scholar] [CrossRef] [Green Version]
  30. Bai, M.; Zheng, C.-J.; Tang, D.-Q.; Zhang, F.; Wang, H.-Y.; Chen, G.-Y. Two new secondary metabolites from a mangrove-derived fungus Cladosporium sp. JS1-2. J. Antibiot. 2019, 72, 779–782. [Google Scholar] [CrossRef]
  31. Yamazaki, H.; Yagi, A.; Akaishi, M.; Kirikoshi, R.; Takahashi, O.; Abe, T.; Chiba, S.; Takahashi, K.; Iwakura, N.; Namikoshi, M.; et al. Halogenated cladosporols produced by the sodium halide-supplemented fermentation of the plant-associated fungus Cladosporium sp. TMPU1621. Tetrahedron Lett. 2018, 59, 1913–1915. [Google Scholar] [CrossRef]
  32. Nasini, G.; Arnone, A.; Assante, G.; Bava, A.; Moricca, S.; Ragazzi, A. Secondary mould metabolites of Cladosporium tenuissimum, a hyperparasite of rust fungi. Phytochemistry 2004, 65, 2107–2111. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Neohelicosporium griseum (GZAAS 22-2002) (a,b) Colonies on natural substrates. (cf,h) Conidiophores and conidia. (g,im) Conidiogenous cells and conidia. (or) Conidia. (n) Germinated conidium. (s,t) Culture on a PDA from above and reverse. Scale bars: (ce,h,nr) 20 μm, (fg,im) 10 μm.
Figure 1. Neohelicosporium griseum (GZAAS 22-2002) (a,b) Colonies on natural substrates. (cf,h) Conidiophores and conidia. (g,im) Conidiogenous cells and conidia. (or) Conidia. (n) Germinated conidium. (s,t) Culture on a PDA from above and reverse. Scale bars: (ce,h,nr) 20 μm, (fg,im) 10 μm.
Metabolites 13 00435 g001
Figure 2. Phylogenetic tree generated from IQ-Tree v.2 analysis based on analysis of a combined set of LSU, ITS, TEF1α, and RPB2 sequence data. Bootstrap support values of maximum likelihood (ML) equal to or greater than 75% and Bayesian posterior probabilities (PP) equal to or greater than 0.95 are given near the nodes as ML/PP. Acanthohelicospora aurea (GZCC 16-0060) and A. pinicola (MFLUCC 10-0116) were used as outgroup taxa. The newly generated sequence is indicated in bold red.
Figure 2. Phylogenetic tree generated from IQ-Tree v.2 analysis based on analysis of a combined set of LSU, ITS, TEF1α, and RPB2 sequence data. Bootstrap support values of maximum likelihood (ML) equal to or greater than 75% and Bayesian posterior probabilities (PP) equal to or greater than 0.95 are given near the nodes as ML/PP. Acanthohelicospora aurea (GZCC 16-0060) and A. pinicola (MFLUCC 10-0116) were used as outgroup taxa. The newly generated sequence is indicated in bold red.
Metabolites 13 00435 g002
Figure 3. Chemical structures of compounds 17 isolated from Neohelicosporium griseum.
Figure 3. Chemical structures of compounds 17 isolated from Neohelicosporium griseum.
Metabolites 13 00435 g003
Figure 4. Key COSY, Key NOSEY, and HMBC correlations of compounds 13.
Figure 4. Key COSY, Key NOSEY, and HMBC correlations of compounds 13.
Metabolites 13 00435 g004
Figure 5. Linear regression analysis between experimental and calculated 13C NMR chemical shifts of isomers of 1.
Figure 5. Linear regression analysis between experimental and calculated 13C NMR chemical shifts of isomers of 1.
Metabolites 13 00435 g005
Figure 6. Calculated and experimental ECD spectra of compounds 1 and 2.
Figure 6. Calculated and experimental ECD spectra of compounds 1 and 2.
Metabolites 13 00435 g006
Figure 7. Linear regression analysis between experimental and calculated 13C NMR chemical shifts of isomers of 2.
Figure 7. Linear regression analysis between experimental and calculated 13C NMR chemical shifts of isomers of 2.
Metabolites 13 00435 g007
Figure 8. Calculated and experimental ECD spectra of compound 3.
Figure 8. Calculated and experimental ECD spectra of compound 3.
Metabolites 13 00435 g008
Figure 9. The effect of Neogrisphenol A on A2780 cell growth at various doses. (A) The chemical structure of NeoA; (B) The MTT test was used to detect the inhibitory impact of NeoA on the proliferation of A2780 cells; (C) The semi-inhibitory concentration (IC50) values of NeoA at various periods (24, 48, and 72 h); (D) Using an inverted microscope (magnification = 100×), morphological alterations in A2780 cells treated with various doses of NeoA for 24 h were detected; (E) Flow cytometry was used to assess the apoptosis of A2780 cells; (F) Flow cytometry was used to detect cell cycle alterations in the A2780 cell line in the control (DMSO) and NeoA groups at various doses; (G) The total rate of apoptosis in A2780 cells that were treated with various concentrations of NeoA; (H) A comparison of the effects of various concentrations of NeoA on the early and late apoptosis rates in A2780 cells; (I) The proportion of A2780 cells in each of the three cell-cycle stages altered following treatment with NeoA. The data is presented as the mean ± SD (n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. the control (DMSO) group; n.s, non-significant. For statistical analysis, one-way ANOVA and multiple t tests were both performed.
Figure 9. The effect of Neogrisphenol A on A2780 cell growth at various doses. (A) The chemical structure of NeoA; (B) The MTT test was used to detect the inhibitory impact of NeoA on the proliferation of A2780 cells; (C) The semi-inhibitory concentration (IC50) values of NeoA at various periods (24, 48, and 72 h); (D) Using an inverted microscope (magnification = 100×), morphological alterations in A2780 cells treated with various doses of NeoA for 24 h were detected; (E) Flow cytometry was used to assess the apoptosis of A2780 cells; (F) Flow cytometry was used to detect cell cycle alterations in the A2780 cell line in the control (DMSO) and NeoA groups at various doses; (G) The total rate of apoptosis in A2780 cells that were treated with various concentrations of NeoA; (H) A comparison of the effects of various concentrations of NeoA on the early and late apoptosis rates in A2780 cells; (I) The proportion of A2780 cells in each of the three cell-cycle stages altered following treatment with NeoA. The data is presented as the mean ± SD (n = 3). * p < 0.05, ** p < 0.01, *** p < 0.001 vs. the control (DMSO) group; n.s, non-significant. For statistical analysis, one-way ANOVA and multiple t tests were both performed.
Metabolites 13 00435 g009
Table 1. Nucleotide differences between the new isolate and the other four known isolates of Helicosporium griseum in the ITS and LSU regions.
Table 1. Nucleotide differences between the new isolate and the other four known isolates of Helicosporium griseum in the ITS and LSU regions.
Strains No.ITS SequenceLSU Sequence
Position 410Position 458Position 460Position 7Position 161Position 496
GZCC 22-2002TGGCCC
CBS 113542TTACCT
CBS 961.69 TGATCT
JCM 9265CGA-TT
UAMH 1694 CGATCT
Table 2. The 1H (600 MHz) and 13C NMR (150 MHz) Data of Compounds 1 and 2 in DMSO-d6.
Table 2. The 1H (600 MHz) and 13C NMR (150 MHz) Data of Compounds 1 and 2 in DMSO-d6.
12
NoδC, TypeδH (J in Hz)δC, TypeδH (J in Hz)
1205.1, C 205.0, C
232.8, CH23.14, dd (17.7, 13.3), Ha
2.49, dd (17.7, 3.9), Hb
33.2, CH23.03, dd (17.6, 13.4), Ha
2.25, dd (17.6, 3.8), Hb
349.2, CH2.61, ddd (13.3, 3.9, 2.0)48.8, CH2.57, ddd (13.4, 3.8, 2.0)
465.9, CH4.87, d (4.2)65.7, CH4.98, d (4.9)
4a145.7, C 146.0, C
5119.7, CH6.88, overlap119.5, CH6.89, overlap
6137.1, CH7.51, dd (8.4, 7.4)137.2, CH7.53, dd (7.9, 7.9)
7117.1, CH6.88, overlap117.0, CH6.89, overlap
8161.4, C 161.4, C
8a114.7, C 114.7, C
1′206.4, C 203.4, C
2′73.5, C 73.6, C
3′136.3, CH6.35, d (10.0)136.8, CH6.43, d (10.0)
4′125.7, CH6.74, d (10.0)125.3, CH6.61, d (10.0)
4a’137.6, C 139.6, C
5′118.9, CH6.88, overlap107.9, CH6.31, d (2.2)
6′137.8, CH7.56, dd (8.4, 7.4)166.2, C
7′117.1, CH6.88, overlap101.5, CH6.17, d (2.2)
8′161.5, C 164.8, C
8a’113.2, C 106.7, C
4-OH 5.52, br d (4.2) 5.50, br d (4.9)
8-OH 12.17, s 12.12, s
2′-OH 6.10, br s 6.03, br s
6′-OH 10.94, s
8′-OH 12.19, s 12.68, s
Table 3. The 1H (600 MHz) and 13C NMR (150 MHz) data for compound 3 in DMSO-d6.
Table 3. The 1H (600 MHz) and 13C NMR (150 MHz) data for compound 3 in DMSO-d6.
3
NoδC, TypeδH (J in Hz)
1161.8, C
2
372.3, CH4.36, dqd (12.0, 6.2, 2.8)
432.8, CH22.54, dd (16.5, 12.0), Ha 2.93, dd (16.5, 2.8), Hb
4a112.6, C
5142.0, C
6160.7, C
7160.5, C
897.8, CH6.47, s
8a104.8, C
920.5, CH31.35, d (6.2)
1010.6, CH31.98, s
1155.4, OCH33.71, s
6-OH 10.41, br s
Table 4. Minimum inhibitory concentrations (MIC, µg/mL) of 12 and 5 against bacterial test organisms.
Table 4. Minimum inhibitory concentrations (MIC, µg/mL) of 12 and 5 against bacterial test organisms.
CompoundB. subtilisC. perfringensR. solanacarumMRSA Stain ATCC43300S. aureus
115.6331.2515.6331.2531.25
2---31.25-
5-250.00---
ciprofloxacin0.630.080.320.320.08
Table 5. Antifungal activity of compound 5 against plant pathogenic fungi.
Table 5. Antifungal activity of compound 5 against plant pathogenic fungi.
CompoundP. nicotianae var. nicotianaeS. asclerotiorum
IC50 (µg/mL)
552.36 ± 1.3888.14 ± 2.21
Table 6. Cytotoxicity of 17 against mammalian cell lines [half maximal inhibitory concentration (IC50): µM].
Table 6. Cytotoxicity of 17 against mammalian cell lines [half maximal inhibitory concentration (IC50): µM].
CompoundA2780PC-3MBA-MD-231
13.2010.6816.30
210.13>20>20
3>20>20>20
4>20>20>20
5>20>20>20
6>20>20>20
7>20>20>20
cis-platinum9.347.53-
adriamycin--12.71
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zhang, L.-J.; Yang, M.-F.; Ma, J.; Xiao, X.-J.; Ma, X.-Y.; Zheng, D.-G.; Han, M.-Y.; Xia, M.-L.; Jayawardena, R.S.; Mapook, A.; et al. Neogrisphenol A, a Potential Ovarian Cancer Inhibitor from a New Record Fungus Neohelicosporium griseum. Metabolites 2023, 13, 435. https://doi.org/10.3390/metabo13030435

AMA Style

Zhang L-J, Yang M-F, Ma J, Xiao X-J, Ma X-Y, Zheng D-G, Han M-Y, Xia M-L, Jayawardena RS, Mapook A, et al. Neogrisphenol A, a Potential Ovarian Cancer Inhibitor from a New Record Fungus Neohelicosporium griseum. Metabolites. 2023; 13(3):435. https://doi.org/10.3390/metabo13030435

Chicago/Turabian Style

Zhang, Li-Juan, Ming-Fei Yang, Jian Ma, Xing-Juan Xiao, Xiao-Yan Ma, De-Ge Zheng, Mei-Yan Han, Ming-Lei Xia, Ruvishika S. Jayawardena, Ausana Mapook, and et al. 2023. "Neogrisphenol A, a Potential Ovarian Cancer Inhibitor from a New Record Fungus Neohelicosporium griseum" Metabolites 13, no. 3: 435. https://doi.org/10.3390/metabo13030435

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop